Anthony Sileno

640 total citations
10 papers, 499 citations indexed

About

Anthony Sileno is a scholar working on Pharmaceutical Science, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Anthony Sileno has authored 10 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 2 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in Anthony Sileno's work include Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Anthony Sileno is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Anthony Sileno collaborates with scholars based in United States, South Africa and India. Anthony Sileno's co-authors include Christian Behl, Steven C. Quay, Gordon Brandt, Henry R. Costantino, Alexis Leonard, C A Foerder, Michael E. Houston, Daniel L. Morris, Paul H. Johnson and Edward G. Langenback and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and International Journal of Pharmaceutics.

In The Last Decade

Anthony Sileno

10 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Sileno United States	7	316	128	66	50	48	10	499
Jacob Rune Jørgensen Denmark	8	101 0.3×	188 1.5×	70 1.1×	65 1.3×	26 0.5×	13	591
Mariacristina Castelli United States	10	110 0.3×	98 0.8×	17 0.3×	21 0.4×	42 0.9×	19	399
Satyanarayana Valiveti United States	15	266 0.8×	51 0.4×	14 0.2×	72 1.4×	263 5.5×	20	602
Mennatallah A. Gowayed Egypt	14	46 0.1×	174 1.4×	33 0.5×	23 0.5×	66 1.4×	33	486
Reto Engel Switzerland	7	65 0.2×	45 0.4×	66 1.0×	31 0.6×	12 0.3×	11	410
Michael C. Makoid United States	11	159 0.5×	115 0.9×	18 0.3×	29 0.6×	51 1.1×	26	517
Kunio Nakanishi Japan	11	124 0.4×	82 0.6×	14 0.2×	43 0.9×	38 0.8×	37	342
Shigeharu Yokohama Japan	12	237 0.8×	83 0.6×	14 0.2×	60 1.2×	22 0.5×	22	456
Lingyan Yu China	17	41 0.1×	252 2.0×	92 1.4×	28 0.6×	69 1.4×	65	773
Bhavna Kumar India	12	348 1.1×	168 1.3×	86 1.3×	35 0.7×	31 0.6×	37	623

Countries citing papers authored by Anthony Sileno

Since Specialization

Citations

This map shows the geographic impact of Anthony Sileno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Sileno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Sileno more than expected).

Fields of papers citing papers by Anthony Sileno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Sileno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Sileno. The network helps show where Anthony Sileno may publish in the future.

Co-authorship network of co-authors of Anthony Sileno

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Sileno. A scholar is included among the top collaborators of Anthony Sileno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Sileno. Anthony Sileno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Johnson, Franklin K., Shirley Wu, Hadis Williams, et al.. (2024). Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatment. PLoS ONE. 19(12). e0314030–e0314030. 3 indexed citations

Chien, Yin‐Hsiu, Benedikt Schoser, Priya S. Kishnani, et al.. (2022). Immunogenicity of cipaglucosidase alfa/miglustat versus alglucosidase alfa/placebo in late-onset Pompe disease (LOPD): A phase III, randomized study (PROPEL). Molecular Genetics and Metabolism. 135(2). S30–S30. 2 indexed citations

Mitchell, R., et al.. (2008). Intranasal insulin: PK profile designed specifically for prandial treatment of Type 2 Diabetes. Drug Development Research. 69(3). 143–152. 4 indexed citations

Leonard, Alexis, Anthony Sileno, Gordon Brandt, et al.. (2006). In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo. International Journal of Pharmaceutics. 335(1-2). 138–146. 45 indexed citations

Leonard, Alexis, Daniel L. Morris, Anthony Sileno, et al.. (2006). Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. Journal of Pharmaceutical Sciences. 95(6). 1364–1371. 38 indexed citations

Sileno, Anthony, et al.. (2005). Lower mean weight after 14 days intravenous administration peptide YY3–36 (PYY3–36) in rabbits. International Journal of Obesity. 30(1). 68–72. 35 indexed citations

Leonard, Alexis, et al.. (2005). Development of a novel high-concentration galantamine formulation suitable for intranasal delivery. Journal of Pharmaceutical Sciences. 94(8). 1736–1746. 27 indexed citations

Sileno, Anthony, et al.. (2000). Effects of pH and Dose on Nasal Absorption of Scopolamine Hydrobromide in Human Subjects. Pharmaceutical Research. 17(8). 974–977. 23 indexed citations

Behl, Christian, et al.. (1998). Optimization of systemic nasal drug delivery with pharmaceutical excipients. Advanced Drug Delivery Reviews. 29(1-2). 117–133. 86 indexed citations

10.

Behl, Christian, et al.. (1998). Effects of physicochemical properties and other factors on systemic nasal drug delivery. Advanced Drug Delivery Reviews. 29(1-2). 89–116. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact